MSFS
TMBR

Main Street Financial Solutions’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Main Street Financial Solutions’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-220
Closed -$1K – 473
2022
Q3 		$1K Buy
+220
New +$1.84K ﹤0.01% 426

Other funds holding TMBR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Main Street Financial Solutions's TMBR Position: Q4 2022 in Review

Main Street Financial Solutions sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2022, closing a stake of 220 shares — an estimated $1K sold.

Main Street Financial Solutions first reported a position in TMBR in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 11 funds tracked by Wall St. Rank hold TMBR as of Q4 2022.

  • Main Street Financial Solutions reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Main Street Financial Solutions sold 220 Timber Pharmaceuticals, Inc. shares in Q4 2022, an estimated $1K.
  • Main Street Financial Solutions first reported a position in Timber Pharmaceuticals, Inc. in Q3 2022 and held it in 1 quarter.
  • Main Street Financial Solutions's Timber Pharmaceuticals, Inc. position peaked at $1K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2022.

Based on Main Street Financial Solutions's 13F filing for Q4 2022, filed 30 Jan 2023.